Improving Management of Classical Hodgkin Lymphoma in Children, Adolescents, and Young Adults — Novel Approaches and Their Use in Practice A Closer Look at Novel Checkpoints
Improving Management of Classical Hodgkin Lymphoma in Children, Adolescents, and Young Adults — Novel Approaches and Their Use in Practice A Closer Look at Novel Checkpoints is organized by Projects In Knowledge Inc. (PIK).
Release Date: Mar 10, 2023
Termination Date: Mar 09, 2024
Activity Goal:
The goal of this program is to review new and emerging data about the safety and efficacy of novel therapies, namely, a CD30 antibody-drug conjugate and immune checkpoint inhibitors for pediatric patients with newly-diagnosed or relapsed/refractory classical Hodgkin lymphoma.
Learning Objective(s):
• Devise individualized management plans for children, adolescents, and young adult patients with classical Hodgkin Lymphoma (cHL) consistent with the latest evidence.
• Summarize emerging safety and efficacy data for newer and investigational treatment regimens for cHL.
Additional details will be posted as soon as information is available.